Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer.
Zamboglou C, Bettermann AS, Gratzke C, Mix M, Ruf J, Kiefer S, Jilg CA, Benndorf M, Spohn S, Fassbender TF, Bronsert P, Chen M, Guo H, Wang F, Qiu X, Grosu AL. Zamboglou C, et al. Among authors: grosu al. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1987-1997. doi: 10.1007/s00259-020-05111-3. Epub 2020 Nov 18. Eur J Nucl Med Mol Imaging. 2021. PMID: 33210239 Free PMC article.
11C-Choline PET/pathology image coregistration in primary localized prostate cancer.
Grosu AL, Weirich G, Wendl C, Prokic V, Kirste S, Geinitz H, Souvatzoglou M, Gschwend JE, Schwaiger M, Molls M, Weber WA, Treiber U, Krause BJ. Grosu AL, et al. Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2242-8. doi: 10.1007/s00259-014-2861-0. Epub 2014 Sep 4. Eur J Nucl Med Mol Imaging. 2014. PMID: 25186430
Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only.
Rischke HC, Schultze-Seemann W, Wieser G, Krönig M, Drendel V, Stegmaier P, Krauss T, Henne K, Volegova-Neher N, Schlager D, Kirste S, Grosu AL, Jilg CA. Rischke HC, et al. Among authors: grosu al. Strahlenther Onkol. 2015 Apr;191(4):310-20. doi: 10.1007/s00066-014-0763-5. Epub 2014 Oct 18. Strahlenther Onkol. 2015. PMID: 25326142
A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
Schimek-Jasch T, Troost EG, Rücker G, Prokic V, Avlar M, Duncker-Rohr V, Mix M, Doll C, Grosu AL, Nestle U. Schimek-Jasch T, et al. Among authors: grosu al. Strahlenther Onkol. 2015 Jun;191(6):525-33. doi: 10.1007/s00066-015-0812-8. Epub 2015 Feb 10. Strahlenther Onkol. 2015. PMID: 25665799
Improved inter-observer agreement of an expert review panel in an oncology treatment trial--Insights from a structured interventional process.
Nestle U, Rischke HC, Eschmann SM, Holl G, Tosch M, Miederer M, Plotkin M, Essler M, Puskas C, Schimek-Jasch T, Duncker-Rohr V, Rühl F, Leifert A, Mix M, Grosu AL, König J, Vach W. Nestle U, et al. Among authors: grosu al. Eur J Cancer. 2015 Nov;51(17):2525-33. doi: 10.1016/j.ejca.2015.07.036. Epub 2015 Aug 12. Eur J Cancer. 2015. PMID: 26277100 Clinical Trial.
MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
Zamboglou C, Wieser G, Hennies S, Rempel I, Kirste S, Soschynski M, Rischke HC, Fechter T, Jilg CA, Langer M, Meyer PT, Bock M, Grosu AL. Zamboglou C, et al. Among authors: grosu al. Eur J Nucl Med Mol Imaging. 2016 May;43(5):889-897. doi: 10.1007/s00259-015-3257-5. Epub 2015 Nov 23. Eur J Nucl Med Mol Imaging. 2016. PMID: 26592938
434 results